Weiss Asset Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CANO.WS
LP
ICM
UFM
AWG
ZA
GL
DCM
Weiss Asset Management's CANO.WS Position: Q3 2022 in Review
Weiss Asset Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q3 2022, closing a stake of 54,125 shares — an estimated $37K sold.
Weiss Asset Management first reported a position in CANO.WS in Q4 2021 and held it in 3 quarters. The position peaked at $129K in Q4 2021. 30 funds tracked by Wall St. Rank hold CANO.WS as of Q3 2022.
- Weiss Asset Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q3 2022 after selling out during the quarter.
- Weiss Asset Management sold 54,125 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q3 2022, an estimated $37K.
- Weiss Asset Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 3 quarters.
- Weiss Asset Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $129K in Q4 2021.
- 30 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q3 2022.
Based on Weiss Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.